Carmen Valcarce
Chief Tech/Sci/R&D Officer at VTV THERAPEUTICS INC.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Richard Nelson | M | 54 |
vTv Therapeutics LLC
vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | 4 years |
Stephen L. Holcombe | M | 66 |
vTv Therapeutics LLC
vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | 7 years |
Hersh Kozlov | M | 76 |
vTv Therapeutics LLC
vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | 5 years |
Noel Spiegel | M | 76 |
vTv Therapeutics LLC
vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | 8 years |
John Fry | M | 64 |
vTv Therapeutics LLC
vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | 8 years |
Howard Weiner | M | 78 |
vTv Therapeutics LLC
vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | 7 years |
Robin Abrams | F | 60 |
vTv Therapeutics LLC
vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | 8 years |
Paul Sekhri | M | 66 | 2 years | |
Imogene Dunn | M | - |
vTv Therapeutics LLC
vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | - |
Carl Johan Kördel | M | 62 |
University of Lund
| 40 years |
Fahed Al Marzooqi | M | 45 | 2 years | |
Aaron H. Burstein | M | - |
vTv Therapeutics LLC
vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | - |
Robert C. Andrews | M | - |
vTv Therapeutics LLC
vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | 18 years |
Samuel B. Rollins | M | - |
vTv Therapeutics LLC
vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | 18 years |
Paul G. Savas | M | 61 |
vTv Therapeutics LLC
vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | 6 years |
Gustavo Matías Clavero | M | 72 |
Universidad Autónoma de Madrid
| 38 years |
Thomas Strack | M | - | 1 years | |
Jennifer Freeman | F | - | - | |
Vanessa McDade | F | - | - | |
Barry Brown | M | 63 | 2 years | |
Raymond Cheong | M | 42 | - | |
Tomas Leanderson | M | 68 |
University of Lund
| 34 years |
Margareta Linden | M | - |
University of Lund
| 31 years |
Guido Zacchi | M | 74 |
University of Lund
| 35 years |
Catharina Svanborg | M | 75 |
University of Lund
| 35 years |
Lars Magnus Thomas Bjursten | M | 75 |
University of Lund
| 35 years |
Glenn Silver | M | - |
vTv Therapeutics LLC
vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | - |
Petr Dejmek | M | 79 |
University of Lund
| 35 years |
Elizabeth M. Keiley | F | 58 | 1 years | |
Tommy Evert Andersson | M | 68 |
University of Lund
| 28 years |
Srini Akkaraju Akkaraju | M | 56 | - | |
Steven Tuch | M | 56 | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Filip Tobias Petersson | M | 47 |
University of Lund
| 10 years |
Deepa Prasad | F | 44 | 1 years | |
Marten Steen | M | 49 |
University of Lund
| 9 years |
Rudy Howard | M | 67 | 6 years | |
Bengt Karlsson | M | - |
University of Lund
| 5 years |
Chandresh Harjivan | M | 55 | 1 years | |
Rikard Krook | M | 57 |
University of Lund
| 5 years |
Fredrik Häglund | M | 49 |
University of Lund
| 6 years |
Susanna Schneeberger | F | 51 |
University of Lund
| 1 years |
Lars Bertil Christer Wingren | M | 58 |
University of Lund
| 8 years |
John Erik Syrén | M | 46 |
University of Lund
| 3 years |
Måns Nicklas Lidgren | M | 47 |
University of Lund
| 5 years |
Inga Sarah Maria Fredriksson | M | 56 |
University of Lund
| 5 years |
Ulrika Ringdahl | F | - |
University of Lund
| 11 years |
Keith Harris | M | 71 | 2 years | |
Craig Parker | M | 63 | 4 years | |
Trey M. Lambert | M | - | - | |
Hector Rodriguez | M | - |
Universidad Autónoma de Madrid
| 5 years |
Jonathan Isaacsohn | M | 70 | 2 years | |
Jacob Uno Stanley Gunterberg | M | 57 |
University of Lund
| 4 years |
Jeanette Andersson | F | 56 |
University of Lund
| 3 years |
Staffan Mattson | M | 62 |
University of Lund
| 1 years |
Per Stefan Andersson-Engels | M | 64 |
University of Lund
| 3 years |
Hans Åke Karl Petersson | M | 58 |
University of Lund
| 5 years |
Peter Platan | M | - |
University of Lund
| 5 years |
Sven Erik Holmgren | M | 63 |
University of Lund
| 3 years |
Nicklas Lindberg | M | - |
University of Lund
| 4 years |
Louise Wendel | F | 49 |
University of Lund
| 6 years |
Mats Säterberg | M | 61 |
University of Lund
| 4 years |
Gunilla Andersson | F | 63 |
University of Lund
| 4 years |
Daniel Modéus | M | 54 |
University of Lund
| 3 years |
Peter Montgomery | M | 50 |
University of Lund
| 5 years |
Pia Susanne Persson | F | 55 |
University of Lund
| 1 years |
Ronnie Ekman | M | - |
University of Lund
| 4 years |
Beatriz Corredor Sierra | F | 55 |
Universidad Autónoma de Madrid
| 3 years |
Anders Thorsson | M | 57 |
University of Lund
| 1 years |
Finn Persson | M | - |
University of Lund
| 5 years |
Ming Hua Li | M | 73 |
University of Lund
| 3 years |
Louise Öfverström | F | 49 |
University of Lund
| 2 years |
Cecilia Schéele | F | - |
University of Lund
| 4 years |
Kristín Haraldsdóttir | F | 54 |
University of Lund
| 3 years |
Jan Staffan Helgesson | M | 56 |
University of Lund
| 4 years |
Lars Magnus Lindhe | M | 59 |
University of Lund
| 5 years |
Erik B. Larsson | M | 57 |
University of Lund
| 4 years |
Björn Jonas Ohlsson | M | 55 |
University of Lund
| 3 years |
Martin Magnusson | M | - |
University of Lund
| 3 years |
Miguel Medina | M | - |
Universidad Autónoma de Madrid
| 3 years |
Nils Olof Jarlman | M | 70 |
University of Lund
| 3 years |
Bo Ahrén | M | 72 |
University of Lund
| 16 years |
Fredrik Ekström | M | - |
University of Lund
| 1 years |
Pablo Ortiz Betes | M | - |
Universidad Autónoma de Madrid
| 3 years |
Staffan Skogvall | M | 61 |
University of Lund
| 3 years |
Michael Reza Mokhberi | M | 53 |
University of Lund
| 1 years |
Antonio Cordero Gómez | M | - |
Universidad Autónoma de Madrid
| 4 years |
Friðrik Bragason | M | 56 |
University of Lund
| 3 years |
Johan Moeschlin | M | - |
University of Lund
| 4 years |
Gloria Martín Gimeno | F | - |
Universidad Autónoma de Madrid
| 4 years |
Patrik Romberg | M | 58 |
University of Lund
| 3 years |
Bertil Lindmark | M | 68 |
University of Lund
| 5 years |
Elena Pisonero Ruiz | F | 61 |
Universidad Autónoma de Madrid
| 4 years |
Teresa León Colombo | M | - |
Universidad Autónoma de Madrid
| 4 years |
Maximino Carpio García | M | - |
Universidad Autónoma de Madrid
| 1 years |
Åsa Schiött | M | - |
University of Lund
| 3 years |
Martin Anders Persson | M | 49 |
University of Lund
| 4 years |
Diego J. Ruiz | M | 56 |
Universidad Autónoma de Madrid
| 4 years |
Dag Jörgen Urban Gustafsson | M | - |
University of Lund
| 3 years |
Johan Ek | M | - |
University of Lund
| 5 years |
Mats Svensson | M | 60 |
University of Lund
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
Sweden | 59 | 59.00% |
United States | 30 | 30.00% |
Spain | 11 | 11.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Carmen Valcarce
- Personal Network